Talk:Sunitinib
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. (August 2006) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
Contents |
[edit] Unreferenced?
The Aug 2006 unreferenced tag is on the discussion page. I think it's supposed to be on the article. Regardless, is it still a valid concern as the article does have some external links and cites the NEJM? Canuckle 18:52, 22 May 2007 (UTC)
[edit] Uncritically pro-drug
States that sunitinib is the drug of choice for GIST - clearly not the case, imatinib is current proven therapy and there are currently no RCTs comparing the two. cave —Preceding unsigned comment added by 144.134.175.93 (talk) 12:29, 11 October 2007 (UTC)
[edit] Too technical
This article is too technical for the average reader imho. It also fails to address the issues which brought me here - the funding debate over this drug and my unanswered questions, what is it made of and why is it so expensive? --kingboyk 09:29, 13 August 2007 (UTC)
[edit] Other Safety issues
This article misses some key issues of safety related to tyrosine kinase inhibitors, specifically multiple cardiac targets and potential clinical effects. See this article for example: [1]
[edit] Drug company advertising?
This is not an entry in an encyclopedia. This would not even be legal as advertising - it makes it sound like an unqualified cure-all - and it shouldn't be presented like this in a reference work. 130.209.6.40 (talk) 10:19, 20 November 2007 (UTC)

